Andrew S Bomback - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Andrew S Bomback

Showing results (71-80 of 200) with videos related to

Pageof 20

Sort By:

Advances in Chronic Kidney Disease|February 24, 2015

Aldosterone blockade in CKD: emphasis on pharmacologyMichael H Schwenk, Jamie S Hirsch, Andrew S Bomback

Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2015

Drug-induced glomerular disease: direct cellular injuryGlen S Markowitz, Andrew S Bomback, Mark A Perazella

Kidney International|June 24, 2021

The Authors ReplyAndrew S Bomback, Vimal K Derebail, Abhijit V Kshirsagar

Journal of the American Society of Nephrology : JASN|July 14, 2025

Barriers to Patients Accessing Specialized Treatments for Glomerular DiseasesBrian Monk, Brian Ewert, Andrew S Bomback, et al.

Journal of Clinical Medicine|April 30, 2021

Glomerular Diseases in Diabetic Patients: Implications for Diagnosis and ManagementNestor Oliva-Damaso, José María Mora-Gutiérrez, Andrew S Bomback

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2023

Complement inhibitors for kidney diseaseBenjamin Wooden, Blanca Tarragon, Mariela Navarro-Torres, et al.

Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|October 30, 2009

Disordered aldosterone-volume relationship in end-stage kidney diseaseAndrew S Bomback, Abhijit V Kshirsagar, Maria E Ferris, et al.

Advances in Kidney Disease and Health|April 2, 2025

PodocytopathiesMariela Navarro-Torres, Benjamin Wooden, Dominick Santoriello, et al.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2008

Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic reviewAndrew S Bomback, Abhijit V Kshirsagar, M Ahinee Amamoo, et al.

Kidney International|May 17, 2021

Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccineVivette D D'Agati, Satoru Kudose, Andrew S Bomback, et al.

Pageof 20

Search research articles

Showing results (71-80 of 200) with videos related to

Sort By:

Pageof 20

Advances in Chronic Kidney Disease|February 24, 2015

Aldosterone blockade in CKD: emphasis on pharmacologyMichael H Schwenk, Jamie S Hirsch, Andrew S Bomback

Clinical Journal of the American Society of Nephrology : CJASN|April 12, 2015

Drug-induced glomerular disease: direct cellular injuryGlen S Markowitz, Andrew S Bomback, Mark A Perazella

Kidney International|June 24, 2021

The Authors ReplyAndrew S Bomback, Vimal K Derebail, Abhijit V Kshirsagar

Journal of the American Society of Nephrology : JASN|July 14, 2025

Barriers to Patients Accessing Specialized Treatments for Glomerular DiseasesBrian Monk, Brian Ewert, Andrew S Bomback, et al.

Journal of Clinical Medicine|April 30, 2021

Glomerular Diseases in Diabetic Patients: Implications for Diagnosis and ManagementNestor Oliva-Damaso, José María Mora-Gutiérrez, Andrew S Bomback

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2023

Complement inhibitors for kidney diseaseBenjamin Wooden, Blanca Tarragon, Mariela Navarro-Torres, et al.

Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|October 30, 2009

Disordered aldosterone-volume relationship in end-stage kidney diseaseAndrew S Bomback, Abhijit V Kshirsagar, Maria E Ferris, et al.

Advances in Kidney Disease and Health|April 2, 2025

PodocytopathiesMariela Navarro-Torres, Benjamin Wooden, Dominick Santoriello, et al.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2008

Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic reviewAndrew S Bomback, Abhijit V Kshirsagar, M Ahinee Amamoo, et al.

Kidney International|May 17, 2021

Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccineVivette D D'Agati, Satoru Kudose, Andrew S Bomback, et al.

Pageof 20